Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD)

NCT03415854 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Pancreatic Ductal Adenocarcinoma
Pancreatic Adenocarcinoma
Pancreas Metastases
Adenocarcinoma

Interventions

DRUG: Paricalcitol (Zemplar)

Sponsor

HonorHealth Research Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]